Clinical Research Protocol Development

The contract seeks the development of a clinical trial protocol focused on creating individualized exercise recommendations for breast cancer survivors, with an emphasis on designing scientifically rigorous study objectives, methodology, and data collection procedures. The protocol must outline clear endpoints, participant inclusion and exclusion criteria, exercise intervention components, safety monitoring protocols, and methods for measuring physical and psychological outcomes over time, ensuring alignment with current clinical guidelines and evidence-based practices in oncology rehabilitation. The project requires collaboration with multidisciplinary experts to tailor exercise prescription based on survivor characteristics such as treatment history, physical function, and comorbidities. Work under this subcontract is to be performed in Bethesda, Maryland, with a submission deadline of July 23, 2026, and is categorized under NAICS code 541611 for scientific research and development services. The awarding agency is the National Institutes of Health under the Department of Health and Human Services, indicating that the final protocol will support federal research initiatives aimed at improving the long-term quality of life for cancer survivors. Proposers are expected to demonstrate expertise in clinical trial design, oncology rehabilitation, and data management, with an ability to produce a protocol suitable for IRB review and future funding applications.